PerkinElmer to Present at UBS Global Life Sciences Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Sept. 16, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008, at 12:30 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
Robert F. Friel, president and chief executive officer, will provide an overview of the Company, describe its strategy and discuss the outlook for growth.
A live audio webcast of this presentation will also be available on the Investor section of the Company's Web site at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.
PerkinElmer, Inc. is a global technology leader driving growth and innovation in the Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.8 billion in 2007, has approximately 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
CONTACT:
Investor Relations:
PerkinElmer, Inc.
Michael A. Lawless
781-663-5659
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco
781-663-5701
stephanie.wasco@perkinelmer.com